MedEasy, a Bangladesh-based health-tech startup recently secured $750,000 in seed funding from investors. Seedstars International Ventures, Doha Tech Angels (DTA), Startup Bangladesh Limited, Accelerating Asia, and nVentures were involved in the seed round of MedEasy.
The company which was launched in 2020 provides doctor video consultations and home delivery of medication services to its customers. According to Techinasia, the company has over 150,000 users in its platform. The startup believes that it focuses more on serving patients with chronic diseases than its competitors, such as Arogga and Banglameds (acquired by Chaldal). MedEasy’s inventory management system and decentralized distribution network have cut delivery times by 4x compared to its competitors.
Read More: Metlife Bangladesh Launches Fast-Track Dengue Claims Settlement Service
Patricia Sosrodjojo, General Partner at Seedstars International Ventures said about the deal, “MedEasy’s nuanced understanding of Bangladesh’s unique challenges caught our attention. They aren’t just digitizing processes; they’re reshaping healthcare experiences for a demographic often overlooked.”
As part of its efforts to improve medicine availability and decrease delivery time, MedEasy will use a significant portion of the investment to boost its supply chain, technology, and data capabilities.
For more updates, be with Markedium.
